Abiopharma

New Form 8-K - Microbot Medical Inc. Filed: 2025-08-05 AccNo: 0001641172-25-022151 Size: 240 KB Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Veru to Report Fiscal 2025 Third Quarter Financial Results on August 12th

Conduit to Change Name to CDT Equity Inc.

Align Technology Announces $200 Million Open Market Repurchase

Spok-Powered Hospitals Achieve Recognition on U.S. News & World Report’s Best Hospitals Honor Roll

DarioHealth to Report Second Quarter 2025 Results on Tuesday, August 12, 2025

Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, 2025

Senti Bio Determines Recommended Phase 2 Dose (RP2D) in Phase 1 Study of SENTI-202 for the Treatment of Relapsed/Refractory Hematologic Malignancies, Including Acute Myeloid Leukemia

Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025

Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space

Amwell set to continue to enable U.S. Defense Health Agency healthcare teams to deliver connected and seamless in-person and virtual care for the Military Health System (“MHS”)

New Form 10-Q - CURIS INC Filed: 2025-08-05 AccNo: 0001108205-25-000080 Size: 5 MB

New Form 8-K - Vivani Medical, Inc. Filed: 2025-08-05 AccNo: 0001753926-25-001228 Size: 481 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits